Of Flies, Mice, and Men: Evolutionarily Conserved Tissue Damage Responses and Aging  by Neves, Joana et al.
Developmental Cell
ReviewOf Flies, Mice, and Men: Evolutionarily Conserved
Tissue Damage Responses and AgingJoana Neves,1,3 Marco Demaria,1,3 Judith Campisi,1,2,* and Heinrich Jasper1,*
1Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA
2Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94520, USA
3Co-first author
*Correspondence: jcampisi@buckinstitute.org (J.C.), hjasper@buckinstitute.org (H.J.)
http://dx.doi.org/10.1016/j.devcel.2014.11.028
Studies in flies, mice, and human models have provided a conceptual framework for how paracrine interac-
tions between damaged cells and the surrounding tissue control tissue repair. These studies have amassed
evidence for an evolutionarily conserved secretory program that regulates tissue homeostasis. This program
coordinates cell survival and proliferation during tissue regeneration and repair in young animals. By virtue of
chronic engagement, however, it also contributes to the age-related decline of tissue homeostasis leading to
degeneration, metabolic dysfunction, and cancer. Here, we review recent studies that shed light on the
nature and regulation of this evolutionarily conserved secretory program.Introduction
Homeostasis in multicellular organisms depends on a contin-
uous, coordinated response to external and internal insults that
challenge cellular and tissue integrity throughout life. Loss of ho-
meostasis is a hallmark of aging, resulting in pathologies often
caused by defective or deregulated tissue damage responses.
One characteristic of aged mammalian tissues is an accumu-
lation of senescent cells—cells that have ceased dividing,
essentially irreversibly, in response to damage or stress that is
potentially oncogenic (Campisi, 2013). Most senescent cells
secrete a suite of cytokines, growth factors, and proteases,
known as the senescence-associated secretory phenotype
(SASP) (Coppe´ et al., 2008). Because the SASP includes many
proinflammatory cytokines and chemokines, it is thought to be
a driving force behind the low level, chronic inflammation that
causes or exacerbates many age-related pathologies, including
cancer (Coppe´ et al., 2010a). Recent evidence from a transgenic,
prematurely aging mouse model showed that senescent cells
are indeed causal for at least a subset of age-related degenera-
tive diseases, including cataracts and sarcopenia (Baker et al.,
2011).
While the deleterious consequences of the SASP in aging
animals suggest a maladaptive role for senescence in adults,
its coordinated development and complex composition, in-
cluding several growth factors, point to an evolved and adaptive
origin. Indeed, cellular senescence was recently shown to occur
during discrete steps of human and mouse embryonic morpho-
genesis (Mun˜oz-Espı´n et al., 2013; Storer et al., 2013), indicating
at least two adaptive roles in young organisms: tumor suppres-
sion and the fine-tuning of morphogenesis. Further, the SASP
was recently shown to be important for limiting fibrosis and
accelerating tissue repair in the liver and skin in mice (Demaria
et al., 2014; Jun and Lau, 2010; Krizhanovsky et al., 2008).
Understanding the origin and physiological role of this secre-
tory program will not only provide insights into the development
of age-related pathologies, but will also contribute to our under-
standing of homeostasis in young organisms. Strikingly, the
mammalian SASP resembles secretory programs observed inepithelial cells of Drosophila melanogaster (fruit flies). In flies,
this secretory program is evident during development and in
response to tissue injury, suggesting it is an evolutionarily
conserved wounding and tissue damage response. Thus, dis-
secting the regulation and function of the secretory program in
flies may elucidate the mechanisms and consequences of the
SASP in mammals. In this review, we aim to bridge the gap be-
tween research in flies and mammals with regard to cell-nonau-
tonomous mechanisms of growth control and tissue repair. We
posit that developing a common perspective of the conserved
mechanisms that regulate tissue damage responses will accel-
erate the development of effective strategies for treating a host
of age-related pathologies, ultimately in humans.
Paracrine Signaling during Organogenesis
Organogenesis and pattern formation in the embryo and tissue
homeostasis in adults require precise coordination of individual
and collective cellular decisions toward cell proliferation, growth,
and death. Understanding processes that govern this coordina-
tion has therefore been a longstanding focus of developmental
biology, regenerative biology, and cancer research. Studies in
flies show that tissue homeostasis in epithelia is governed by
‘‘collective’’ decision mechanisms that determine cell death
and proliferation across tissues. These mechanisms include
cell competition (CC) and compensatory proliferation (CP) (Vin-
cent et al., 2013). CC and CP have been identified and studied
extensively in flies, and recent studies reveal the existence and
importance of similar processes in mammals, where they main-
tain tissue homeostasis, particularly during tissue repair (Clave-
rı´a et al., 2013; Martins et al., 2014).
CC in Fly Imaginal Discs
CC was initially described in the 1970s in developing Drosophila
wing imaginal discs as a mechanism of cell interaction in which
weaker, yet viable, cells (referred to as ‘‘loser’’ cells) are elimi-
nated by their ‘‘fitter’’ neighbors (referred to as ‘‘winner’’ cells).
The first process in which CC was described was the elimination
ofMinute cells, which harbor defective ribosomal proteins (Mor-
ata and Ripoll, 1975). Decades later, Moreno et al. (2002)Developmental Cell 32, January 12, 2015 ª2015 Elsevier Inc. 9
Table 1. Signaling Pathways Involved in Tissue Damage Responses in Flies and Vertebrates
Signaling Pathway Ligands Receptors Intracellular Pathway
Decapentalegic (Dpp)
signaling
D Decapentalegic (Dpp),
Glass bottom boat (Gbb),
Screw (Scw)
Punt (Put), Thickveins (Tkv),
Saxophone (Sax)
Mothers against dpp (Mad), Medea
Transforming growth
factor b (TGF-b)/bone
morphogenic pathway
(BMP) signaling
V BMP2 and BMP4,
BMP 5,6,7, ?
BMP/Activin receptor type II
(ACTRII), BMP receptor type I
(BMPR1A/B or ALKs), BMP
receptor type I (BMPR1A/B
or ALKs)
SMAD 1/5/8/9, SMAD-4
Wingless (Wg) signaling D Wingless (Wg),
DWnt-2-6,8,10
Frizzled (Fz), Frizzled 2-4
(DFz-2-4)
Armadillo (Arm), Dishevelled (Dsh),
Shaggy (Sgg), Axin
Wnt signaling V WNT-1, WNT-5-8,
10, 14, 15
Frizzled receptors (FZD1-10) beta-catenin (beta-CAT), segment polarity
protein dishevelled homolog (DVL1-3),
glycogen synthase kinase 3 b (GSK3b),
Axin 1-2
JAK/STAT signaling D unpaired proteins (Upd,
Upd-2, Upd-3)
Domeless (Dome) Hopscotch (Hop), Stat92E
V Interleukin-6 (IL-6) type I cytokine receptors Janus kinase (JAKs), signal transducer
and activator of transcription (STATs)
Epidermal growth
factor receptor
(EGFR) signaling
D Vein (Vn), Gurken (Grk),
Spitz (Spi), Keren (Krn),
Argos (Aos)
epidermal growth factor
receptor (EGFR)
Ras, pole hole (Phl)/Raf, downstream
of raf1 (DSor1), rolled (Rl)
V EGF-like ligand similar
to neuregulins, TGF-a
ligands
epidermal growth factor
receptor (EGFR)
rat sarcoma (RAS), RAF-1, MAPK/ERK
kinase (MEK), extracellular-signal-regulated
kinases (ERKs)
Stress signaling
pathways
D Hemipterous (Hep), DMKK4, Li-Corne (Lic),
Basket (Bsk), D-p38a/b
V JNK kinases (JNKKs), mitogen-activated
protein KK 4 (MKK4), mitogen-activated
protein KK 3 (MKK3), c-Jun N-terminal
kinases (JNKs), p38 MAP kinases
(p38 MAPKs)
Drosophila (D) names for themain protein components of pathways involved in paracrine signaling during tissue damage responses andCCare shown.
The vertebrate (V) rows identify known homologs of theDrosophila proteins and are not an exhaustive list of all the components and pathways known to
be part of tissue damage responses in vertebrates.When possible, the nomenclature for human proteins is used. Due to the complexity of the signaling
cascades, the ligands and receptors involved in stress signaling pathways have been omitted.
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due to their defective response to the TGF-b/BMP homolog
Decapentaplegic (Dpp) (see Table 1), which can provide a pro-
survival signal in flies. According to this model, the defective
TGF-b/BMP response in Minute cells results in apoptotic cell
death through activation of the evolutionarily conserved Jun-
N-terminal Kinase (JNK) signaling pathway (Table 1) (Moreno
et al., 2002). Later, it was proposed that the cellular interactions
at population boundaries during CC require not only the
apoptotic death of the Minute cell but also the induction of
engulfment genes (drpr, wasp, and psr) in the winner cells (Li
and Baker, 2007). A similar mechanism was described in the
context of pro-oncogenic clonal expansion in imaginal discs, in
which mutant cells are eliminated by their neighbors. In this
case, the engulfment activity is derived from nonapoptotic
JNK-dependent activation of PVR signaling (Ohsawa et al.,
2011). This mechanism remains controversial, however, as it
was recently proposed that, at least in the context of d-myc-
induced CC, engulfment activity of winner cells is dispensable
for loser cell apoptosis and that most of the cellular clearance
is performed by hemocytes (Lolo et al., 2012). Moreno and col-10 Developmental Cell 32, January 12, 2015 ª2015 Elsevier Inc.leagues further proposed that one mechanism that determines
relative cell viability is mediated by Flower (Fwe), a membrane
receptor that is required for the elimination of loser cells
(Rhiner et al., 2010). This mechanism appears to be conserved
in mammals, where, as in Drosophila, FWE deficiency is associ-
ated with decreased clonal expansion of premalignant cells. It
has been proposed that this decrease is brought about in
FWE-deficient mice by a delay in positive selection for cells
with a proliferative advantage (Petrova et al., 2012; Rhiner
et al., 2010).
CP in Fly Imaginal Discs
CC is tightly linked to CP, a process driven by paracrine signaling
mechanisms that ensure collective decisions in the epithelium.
Apoptotic cells not only collaborate in the competition process
by inducing engulfing activity in their neighbors, but also produce
mitogenic signals that promote CP in the remaining cells (de la
Cova et al., 2004; de la Cova et al., 2014; Moreno and Basler,
2004). Early observations by Alder and Bryant suggested that
lethally irradiated imaginal disc tissues can promote the regener-
ation of neighboring tissues (Adler and Bryant, 1977). In recent
years, the molecular signals promoting CP have been elucidated
Figure 1. Paracrine Signaling in the Control
of Tissue Regeneration, Homeostasis, and
Remodeling
(A) In the posterior midgut epithelium of
Drosophila, damaged enterocytes (ECs) secrete
Upd cytokines upon the activation of stress
signaling involving JNK and Yki. Upds activate the
JAK/STAT signaling pathway of intestinal stem
cells (ISCs), inducing their proliferation and
generating enteroblasts (EBs), which go on to
differentiate into ECs or enteroendocrine (EE) cells.
(B) In imaginal discs, CC results in the induction of
apoptosis in slow-growing cells (‘‘unfit’’ cells, here
exemplified by cells with a lower dose of myc).
Faster-growing cells (‘‘fit’’cells) induce apoptosis
in unfit cells in a p53- and JNK-dependentmanner.
Apoptotic cells, in turn, promote CP by inducing
Dpp, Wg, and Upds.
(C) In the mouse epiblast, fit MYC-overexpressing
cells induce apoptosis and engulfment of unfit
cells, which in turn promote the proliferation of
fit cells through paracrine signals.
(D) In the mouse embryo, activation of the cell-
cycle inhibitor p21 can induce senescence.
Senescent cells, through the SASP, fine-tune
patterning and growth by supporting the survival
and proliferation of neighboring fit cells.
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ficially blocked by expression of transgenic p35 (Huh et al.,
2004; Pe´rez-Garijo et al., 2004, 2005; Ryoo et al., 2004). Notably,
these so-called ‘‘undead’’ cells strongly resemble the phenotype
of senescent mammalian cells. Undead cells are characterized
by their ability to influence the behavior of surrounding cells,
including stimulating cell proliferation by expressing Dpp and
Wingless (Wg), the fly Wnt homolog (Table 1) (Huh et al., 2004;
Pe´rez-Garijo et al., 2004; Ryoo et al., 2004). This paracrine activ-
ity of undead cells occurs in a JNK-dependent manner (Kondo
et al., 2006; Ryoo et al., 2004) and resembles the ability of loser
cells to stimulate winner cell proliferation during CC. It remains
unclear, however, whether the same signaling molecules
mediate CP and CC-induced winner cell proliferation.
Senescent cells, both mouse and human, also stimulate the
growth of neighboring cells by secreting SASP factors, some
of which are potent mitogens (Coppe´ et al., 2010b; Coppe´
et al., 2008). The expression of SASP genes depends on at least
two signaling pathways: the DNA damage response (DDR) and
p38 mitogen-activated protein kinase-nuclear factor kappa
light-chain enhancer of activated B cells (p38MAPK-NF-kB)
pathways (Freund et al., 2011; Rodier et al., 2009).Developmental Cell 3Studies of CC in which a growth advan-
tage was conferred by elevated levels
of d-myc, the Drosophila homolog of
the mammalian proto-oncogene MYC,
showed that paracrine communication
between ‘‘weaker’’ and fitter cells is bidi-
rectional (Figure 1). In this context, cells
overexpressing d-myc, a transcriptional
regulator, induced apoptosis in their
neighbors through expression of the pro-
apoptotic gene hid in a JNK-independent
manner (de la Cova et al., 2004). The
competitive advantage of d-myc overex-pressing cells is p53 dependent (de la Cova et al., 2014). Studies
in culturedDrosophila cells further suggested that this process is
regulated by secreted factors (Senoo-Matsuda and Johnston,
2007). Both cell types—weaker and fitter—participate in the
competition process through paracrine signaling to induce
both apoptotic and proproliferative signals, although specific
factors were not identified in this study (Senoo-Matsuda and
Johnston, 2007).
Moreno and Basler suggested that one mechanism of CC is
mediated by intrinsic changes in the loser cells, which diminish
their ability to respond to a Dpp signal. Accordingly, CC can be
perturbed by enhancing Dpp signaling capacity in the loser cells
(Moreno and Basler, 2004). A recent study on CC in mammalian
cells supports the conservation of both paracrine and cell-
intrinsic mechanisms, since defective Bmp signaling capacity
(through the deletion of Bmp receptors) is sufficient to induce
cell elimination by wild-type cells, and this elimination is
mediated by secreted factors (Sancho et al., 2013). Further sup-
porting the involvement of paracrine signals in CC is the fact that
defects in the endocytic pathway affect the efficiency of CC
(Moreno and Basler, 2004) and can also promote nonautono-
mous overgrowth in imaginal epithelia (Takino et al., 2014).2, January 12, 2015 ª2015 Elsevier Inc. 11
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proposed as yet another mechanism that regulates competitive
advantage in CC interactions (Rodrigues et al., 2012).
It should be noted that in mosaic tissues, winner cells do not
necessarily proliferate faster but may gain a competitive advan-
tage by growing faster (as in the case of d-myc-overexpressing
cells) and/or killing loser cells. In cell culture, on the other
hand, d-myc-overexpressing cells proliferate faster, suggesting
that CC and CPwithin the epithelial context is influenced by con-
straints that are lacking in culture (Senoo-Matsuda and John-
ston, 2007).
Senoo-Matsuda and Johnston’s analysis of cell communica-
tion during CC uncovered the importance of reciprocal cell
signaling in this process. These paracrine interactions between
winner and loser cells in flies are reminiscent of the SASP in
mammals (Coppe´ et al., 2008). Recent studies highlight the
pleiotropic effects of the SASP on the surrounding tissue
environment, which range from autocrine and paracrine rein-
forcement of senescence to promotion of proliferation and cell
recruitment (Tasdemir and Lowe, 2013). It is likely that both the
secretory phenotype and the intrinsic properties of cells exposed
to the SASP may ultimately determine the tissue outcome. In
contrast to the importance of p53 in fly CC (de la Cova et al.,
2014), however, development of the SASP in mammalian cells
is p53 independent (Coppe´ et al., 2008), raising the interesting
question of whether and why this paracrine mechanism lost its
p53 dependence during evolution. On the other hand, senescent
mammalian cells also secrete the evolutionarily conserved,
proinflammatory alarmin HMGB1 in a p53-dependent manner
(Davalos et al., 2013). Thus, HMGB1 secretion may be the
ancestral paracrine mediator, with the SASP developing later
during evolution.
Paracrine Signaling during Mammalian Development
Recently, CC and the SASP were shown to contribute to devel-
opmental programs in mammals. In the mouse embryo, CC was
described in the epiblast as a mechanism to select for cells with
higher MYC levels and anabolic activity, which results in refine-
ment of the initial cell population (Figure 1) (Claverı´a et al.,
2013). Cellular and molecular mechanisms governing CC in the
Drosophila wing disc were also observed in this context,
including induction of a paracrine apoptotic signal by cells over-
expressing MYC and engulfment of apoptotic cells by their
neighbors. Although CC in the mammalian epiblast requires
cell-cell contact (Claverı´a et al., 2013), paracrine factors influ-
encing CC were identified in cultured embryonic stem cells
(Sancho et al., 2013). As in the fly model (Senoo-Matsuda and
Johnston, 2007), this finding indicates that cell culture systems
fail to replicate constraints on cell growth and proliferation in
intact tissues yet are useful for identifying paracrine mediators
of CC and tissue damage responses, an approach that was
also used to identify SASP factors (Coppe´ et al., 2008).
Two recent reports have further identified senescence in the
mammalian embryo as a mechanism of fine-tuning patterning
and growth control (Figure 1) (Mun˜oz-Espı´n et al., 2013; Storer
et al., 2013). These embryonic senescent cells shared a secretory
profile (SASP) with senescent cells found in adult tissues. In the
embryo, as can occur in adult tissues (Iannello et al., 2013;
Kang et al., 2011; Xue et al., 2007), the SASP attracted innate im-
mune cells, which eventually cleared the senescent cells from12 Developmental Cell 32, January 12, 2015 ª2015 Elsevier Inc.developing embryonic structures. In contrast to adult tissues,
however, embryos in which cells failed to undergo senescence
did not appear to be tumor prone. In adults, the senescence
response depends on two tumor suppressor pathways: the
p53/p21 pathway and the p16INK4a/pRB pathway. Senescence
in the embryo, however, was independent of p53 yet strictly
dependent on p21. Indeed, p21-null, but not p53-null, mice
showed defects in embryonic senescence, which was partially
compensated by apoptosis. Loss of senescence did not com-
pletely impair embryogenesis but resulted in delayed patterning
(Mun˜oz-Espı´n et al., 2013; Storer et al., 2013). Thus, the senes-
cence response and SASP appear to fine-tune morphogenesis,
a function that is reminiscent of the role of CCduringmorphogen-
esis in the fly, where CC and CP are observed primarily in
response to genetic or environmental perturbations that confer
a growth advantage or disadvantage to individual cells.
These data highlight the existence of specific signaling mech-
anisms that coordinate the removal of extraneous or abnormal
cells and control the growth and proliferation of neighboring cells
to ensure proper organ morphogenesis. As discussed below, a
strong link between these developmental processes and tumor
suppression in mammals has been established, suggesting a
common origin for these paracrine signaling mechanisms. Of
importance for the maladaptive effects of cellular senescence,
senescent cells in adult tissues are resistant to apoptosis;
when immune-mediated mechanisms of senescent cell clear-
ance are impaired, senescent cells persist beyond the time of
their physiological role, and tissue homeostasis is compromised
(Adams, 2009; Campisi, 2013). Similarly, artificially preventing
apoptosis under conditions in which tissues use CP to compen-
sate for the loss of damaged cells ultimately leads to tissue over-
growth in flies (Huh et al., 2004; Pe´rez-Garijo et al., 2004; Ryoo
et al., 2004). It is important to note that the work in Drosophila
described above also highlights the complexity of the paracrine
processes that control tissue homeostasis, as multiple (and
often conflicting) signaling interactions betweenwinner and loser
cells occur. This complexity is likely a reflection of the heteroge-
neity in tissue microenvironments used to study these interac-
tions and may provide hints for understanding the pleiotropic
effects that senescent cells exert upon their tissue environment
(Ohsawa et al., 2014).
Paracrine Signaling during TissueRegeneration, Repair,
and Remodeling
The paracrine signaling interactions described thus far are crit-
ical for organogenesis during development, and the amazing
regenerative capability of larval imaginal discs has been ex-
ploited to reveal many of the fundamental mechanisms that are
expected to govern epithelial regeneration in many contexts.
Accordingly, similar cell-cell signaling events have been
described in recent years that control tissue homeostasis in
the adult and influence the long-term maintenance of tissue
function. Two general strategies for replacing damaged cells
while maintaining tissue size in adults can be distinguished: CP
of tissue-resident stem cells and compensatory hypertrophy of
postmitotic cells. Here, also, the parallels between signaling
interactions uncovered in Drosophila and interactions between
senescent cells and normal cells that influence aging and cancer
in vertebrates are striking.
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Lessons from the Fly
Compensatory cellular hypertrophy (CCH) was recently reported
in postmitotic tissues in Drosophila, where tissue resident stem
cells are absent and therefore cannot participate in regeneration,
and was also observed in mammalian tissues, including the liver,
cornea, and heart (Tamori and Deng, 2014). In Drosophila follic-
ular epithelia, CC between postmitotic cells results in CCH to
repair tissue loss and fill in lost volume. This compensatory
growth is achieved by paracrine Insulin/IGF-like signaling (IIS),
which accelerates endoreplication in winner cells (Tamori and
Deng, 2013). Similarly, a phenomenon of compensatory hyper-
trophy involving polyploidization and cell fusion, controlled by
the YAP homolog Yorkie (Yki)/Hippo (Hpo) signaling pathway,
was described as a critical mechanism in epidermal wound
closure (Losick et al., 2013). While conceptual similarities exist
between CP and CCH, these results also highlight the diversity
of strategies to achieve compensation for cell loss in different
contexts.
In mitotically active tissues, regenerative processes that rely
on tissue-resident stem cells can maintain homeostasis. Such
processes are particularly important in tissues with high turn-
over, in which stem cells either are continuously cycling or can
rapidly reenter the cell cycle to replenish lost cells. The posterior
midgut epithelium of Drosophila (Figure 1) has been extensively
used to study regenerative processes (Biteau et al., 2011;
Buchon et al., 2013), where stem cells with similar properties
to those found in mammalian tissues were identified (Micchelli
and Perrimon, 2006; Ohlstein and Spradling, 2006). In this tissue,
regeneration after tissue damage is regulated by mechanisms
that are highly reminiscent of CP in developing imaginal discs:
damaged/apoptotic enterocytes (ECs, the major cell type in
the Drosophila midgut) induce proliferation and differentiation
of neighboring intestinal stem cells (ISCs) through paracrine sig-
nals (Jiang et al., 2009). Upon stress, a signaling pathway
involving JNK and the Yki induce the expression of unpaired
cytokines (Upd, Upd2, and Upd3), which signal to ISCs to acti-
vate JAK/STAT signaling and promote their proliferation and dif-
ferentiation (Jiang et al., 2009). Based on their receptors, Upds
are likely functional homologs of mammalian interleukins, espe-
cially interleukin-6 (Table 1) (Agaisse et al., 2003; Arbouzova and
Zeidler, 2006; Harrison et al., 1998).
Further characterization of Upd-mediated paracrine signaling
in the gut has refined our understanding of regenerative signaling
events: Upd1 appears to be the main mediator of stem cell pro-
liferation during homeostatic cell replacement, while Upd2 and
Upd3 act mostly to trigger increased ISC proliferation in
response to acute stress, such as bacterial infection (Osman
et al., 2012).
While paracrine signaling through Upds promotes control of
epithelial regeneration in the gut, ISC proliferation in response
to stress is also modulated by other paracrine and cell-autono-
mous signals. The EGFR ligand Vein, for example, is expressed
in the visceral muscle surrounding the intestinal epithelium and
activates the EGFR/mitogen-activated protein kinase (MAPK)
pathway in ISCs, synergizing with JAK/STAT signaling to pro-
mote ISCs proliferation (see Table 1 for analogies in vertebrates)
(Biteau and Jasper, 2011; Buchon et al., 2010; Jiang et al., 2011).
The AP1 transcription factor Fos integrates JNK stress signalswith EGFR growth factor signals in ISCs to promote proliferation
after stress (Biteau and Jasper, 2011). Similarly, inhibition of the
Nrf2 transcription factor CncC in ISCs is critical for the induction
of regenerative responses to a wide range of damaging stimuli
(Hochmuth et al., 2011; Wang et al., 2014).
Several groups reported involvement of the Hpo pathway in
initiating paracrine Upd and EGF-like signaling (Karpowicz
et al., 2010; Ren et al., 2010; Shaw et al., 2010). Hpo signaling
serves to monitor epithelial integrity, and Hpo inactivation in
ECs induces Upd and EGF, triggering JAK/STAT and EGFR
signaling and subsequent proliferation of ISCs. Interestingly,
cell-autonomous inactivation of the Hpo pathway in ISCs is
also required to trigger the regenerative response (Karpowicz
et al., 2010; Shaw et al., 2010). Yki, which is activated in
response to Hpo silencing, seems to be the mediator of both
paracrine and cell-autonomous functions and is repressed by
Hpo in ISCs under nonstress conditions (Karpowicz et al., 2010).
Paracrine Communication between Epithelial Cells:
The Mammalian Story
Paracrine signaling also plays a critical role in tissue homeostasis
in adult mammals, and the signaling mechanisms are strikingly
similar to those described in flies. IL-6, for example, is one of
the most versatile of mammalian cytokines (Rincon, 2012).
Although IL-6 was originally discovered as an essential factor
in the maturation of B cells (Hirano et al., 1986), it was later found
to have pleiotropic effects in many contexts. In the liver, it is a
critical acute-phase inducer upon injury, and it promotes regen-
eration in response to chemical damage or partial hepatectomy
(Nakamura et al., 2004). In a rat model of spinal cord injury, IL-6
promotes axonal sprouting, synapse formation, and functional
recovery (Yang et al., 2012). During acute kidney injury, IL-6
can both promote an injurious inflammatory response and
protect cells from excessive injury by limiting oxidative stress
(Nechemia-Arbely et al., 2008). In most of these cases, IL-6
signaling mainly activates the transcription factor STAT3, which
exerts several prosurvival, proliferative, migration and inflamma-
tory functions (Levy and Lee, 2002).
IL-6 is a prominent component of the human and mouse
SASPs (Coppe´ et al., 2010b; Coppe´ et al., 2008). Its role in regen-
erative responses and tissue homeostasis highlights a recent
appreciation for the role senescent cells play in these processes
(Adams, 2009; Campisi, 2011). As noted above, the senescence
response comprises a cell-autonomous growth arrest, depen-
dent on the p53/p21 and p16/pRb pathways, which protects
mammalian organisms from cancer (Prieur and Peeper, 2008).
In addition, senescent cells secrete high levels of IL-6 (Coppe´
et al., 2008), which in part reinforces the senescence growth
arrest (Acosta et al., 2008; Kuilman et al., 2008) but also has
potent paracrine effects (e.g., inducing a mesenchymal-epithe-
lial transition in neighboring epithelial cells; Coppe´ et al., 2008).
Further, the SASP comprises a large number of other secreted
molecules, including TGF-b, CCL-20, CCL-2, and VEGF (Acosta
et al., 2013; Coppe´ et al., 2008). Through the SASP, senescent
cells can propagate the senescence response to a limited num-
ber of neighboring cells, thus further deregulating homeostasis
(Acosta et al., 2013).
Other examples of paracrine effects of the SASP include
insulin-like growth factor binding protein 7 (IGFBP7), which is
secreted by cells driven into senescence by oncogenic B-RAFDevelopmental Cell 32, January 12, 2015 ª2015 Elsevier Inc. 13
Developmental Cell
Reviewsignaling and induces senescence or apoptosis in surrounding
cells (Wajapeyee et al., 2008, 2010), and plasminogen activator
inhibitor 1 (PAI-1), which is an important mediator of the senes-
cence growth arrest in both wild-type and p53-deficient cells
(Kortlever et al., 2006).
An important part of the cell-nonautonomous effects of senes-
cent cells is the ability of SASP components to attract and
activate immune cells, which can remove nearby senescent,
damaged, and/or potentially tumorigenic cells. For example, re-
activation of p53 in a mouse model of liver carcinoma leads to
cellular senescence within the tumor and activation of an innate
immune response, which mediates tumor regression (Xue et al.,
2007). In a model of liver cancer due to fibrosis and cirrhosis, a
p53-dependent senescence program in hepatic stellate cells
promotes an antitumor microenvironment through the differenti-
ation of macrophages toward tumor-inhibiting functions (Lujam-
bio et al., 2013). The SASP can also harness the adaptive
immune system to induce CD4+T cell-mediated clearance of
premalignant hepatocytes in the liver, where senescent cells
are targeted by specific Th1 lymphocytes (Kang et al., 2011).
In addition to their anticancer function, cellular senescence
and the SASP play a complex role in promoting tissue recovery
and homeostasis during regenerative episodes. For example,
in response to chemical (carbon tetrachloride) injury in the liver,
activated hepatic stellate cells enter a period of highly active pro-
liferation, during which time they produce the extracellular matrix
that forms a fibrotic scar. These activated stellate cells eventually
become senescent, whereupon they secrete matrix-degrading
enzymes (prominent SASP components) and promote immuno-
surveillance (Krizhanovsky et al., 2008). Similarly, in a model of
cutaneous wound healing, cells in the granulation tissue are
induced to become senescent, whereupon, again, they secrete
enzymes that reduced fibrosis during the last stage of remodel-
ing (Jun and Lau, 2010). During wound healing, senescent
mesenchymal and endothelial cells also appear to be important
for timely wound closure through the secretion of PDGF-AA dur-
ing the proliferative and contraction stage (Demaria et al., 2014).
When Homeostasis Goes Wrong: Cell-Nonautonomous
Signaling in Aging
The function of IL-6-like factors in regenerative responses and
wound healing in both flies and vertebrates highlights the evolu-
tionary conservation of paracrine processes that control tissue
repair. At the same time, work in vertebrates has established a
critical role for the same paracrine signals in senescent cell-
mediated tissue degeneration and even cancer in the aging adult
(Adams, 2009; Campisi, 2013; Rodier and Campisi, 2011). These
findings suggest that in vertebrates, the senescence response
might be antagonistically pleiotropic, having evolved to promote
fitness in young organisms by suppressing cancer and promot-
ing tissue repair but driving aging phenotypes and pathologies in
older organisms. Here, also, studies in flies may significantly
advance our mechanistic understanding of the degenerative
processes associated with aging. We discuss below the nega-
tive consequences of paracrine tissue repair signaling.
During fly development, cell-nonautonomous tumor growth
has been described in Polycomb group (PcG) mutants (Classen
et al., 2009). Here, PcG genes, which are important regulators of
chromatin state, act as tumor suppressors, and their loss results14 Developmental Cell 32, January 12, 2015 ª2015 Elsevier Inc.in hyperproliferation accompanied by loss of tissue integrity in
eye imaginal discs. This is mediated by the induction of Upds,
which appear to be direct targets of PcG-mediated repression.
As in the intestinal epithelium, Upds act in a paracrine manner
to activate JAK/STAT signaling and induce the proliferation of
surrounding cells (Classen et al., 2009).
Nonautonomous tissue overgrowth of fly imaginal discs has
further been described in conditions in which JNK is chronically
activated in imaginal disc cells, yet its proapoptotic function is
masked by prosurvival oncogenic mutations (Figure 2). This phe-
nomenon is observed in Ras/Raf-induced tumors, where cells
with increased ERK activity are refractory to JNK-induced
apoptosis and promote hyperplasia in adjacent wild-type tissue
(Brumby and Richardson, 2003; Igaki et al., 2006; Uhlirova et al.,
2005). This process thus resembles increased tissue growth
induced by undead cells. Although suppression of PcG protein
expression may be one mechanism by which JNK promotes
the expression of Upds to drive proliferation of neighboring cells
in this context (Lee et al., 2005), JNK activation also weakens cell
adhesions and can promote invasive cell behavior in the onco-
genic background (Igaki et al., 2006).
These findings highlight how a beneficial protective mecha-
nism (i.e., JNK-mediated apoptosis of damaged cells) can be
converted into a deleterious condition that promotes hyperplasia
and tumor invasion through paracrine signals. An interesting
aspect to such a hijacking of normal protective mechanisms is
the observation that cells expressing oncogenic signaling mole-
cules can evade high-sugar-diet-induced insulin resistance,
acquiring an undead phenotype that promotes invasiveness
and metastatic behavior by promoting the secretion of wingless
(Hirabayashi et al., 2013).
Aging itself is a risk factor in the development of such pheno-
types. The intestinal epithelium increasingly deteriorates in aging
flies and becomes populated by abnormal clusters of cells that
carry stem cell markers but are polyploid and reach EC-like
size without expressing EC marker genes (Figure 2) (Biteau
et al., 2008; Choi et al., 2008). These changes derive from
increased ISC proliferation and defective differentiation in aged
guts, caused by an imbalance in the normal signaling events
that lead to tissue repair (Biteau et al., 2008, 2011). JNK signaling
is a central player in this context. It is chronically activated in both
ECs and ISCs of aged guts, promoting ISC proliferation and,
in cooperation with Notch signaling, misdifferentiation of ISC
daughter cells. The resulting dysplasia disrupts tissue integrity
and contributes to an age-related increase in mortality (Biteau
et al., 2010; Rera et al., 2011, 2012). Promoting proliferative ho-
meostasis in the intestinal epithelium by limiting JNK activation
and/or insulin signaling can delay these age-associated pheno-
types and increase lifespan (Biteau et al., 2010).
The JNK-associated hyperplastic phenotypes resemble those
induced by undead cells in imaginal discs, suggesting that JNK
activation in the absence of apoptosis may be a general mecha-
nism through which malignant cells propagate (Morata et al.,
2011). Recent data support this hypothesis. Moderate caspase
activity drives cell invasion without promoting apoptosis, and
this phenotype is JNK dependent (Rudrapatna et al., 2013).
In mammals, chronic inflammation is an important character-
istic of aging tissues. It is thought to be a major driver of cellular
damage and to disrupt cellular turnover and tissue homeostasis,
Figure 2. Paracrine Signaling Promotes
Tissue Degeneration and Oncogenic
Phenotypes with Age
(A) The Drosophila intestinal epithelium de-
teriorates with age, becoming populated by
abnormal and dysplastic cells. These cells accu-
mulate as a consequence of JNK-dependent ISC
proliferation and defective differentiation. Different
types of damage, including that caused by infec-
tion and reactive oxygen species (ROS), create
an imbalance of normal signaling events, resulting
in the disruption of tissue integrity due to
chronic activation of stress signaling and chronic
engagement of signaling processes required for
tissue repair in the young epithelium (such as Upd
secretion).
(B) Oncogenic mutations (such as RasV12) in
imaginal disc cell clones can also result in imbal-
anced paracrine signaling that ultimately causes
nonautonomous overgrowth of the tissue. Rasv12
can protect cells from JNK-induced apoptosis.
These undead cells then promote hyperplasia in
the surrounding tissue by continuous secretion of
Upd, Wg, and Dpp.
(C) In vertebrates, senescent cells induced by
different stresses can promote chronic inflamma-
tion, which increases during aging due to an
accumulation of senescent cells. Some SASP
factors (e.g., TGF-b, IGFBP7, PAI-1, CCL2) also
induce a senescence response in neighboring
cells. Inflammation and the spread of senescence
might be the basis for several age-related pathol-
ogies, which are characterized by a disruption of
normal tissue functions.
(D) Several SASP factors (MMP3, VEGF, IL6, IL8,
GRO-a) can also participate in various steps in
tumorigenesis, ranging from proliferation to
migration and invasion. Thus, senescent cells that
accumulate with age and after anticancer DNA-
damaging therapies (chemotherapy, irradiation)
can create a milieu for hyperproliferation and tu-
mor growth in the surrounding tissue.
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(Chung et al., 2009; Franceschi, 2007). The precise origin of
age-related inflammation, or inflammaging, is unknown. One
strong candidate, however, is the SASP of senescent cells that
persist in aged tissues (Figure 2).
In support of this hypothesis, eliminating senescent cells pre-
vents or delays the onset of some age-related pathologies in a
mouse model of accelerated aging (Baker et al., 2011). Further,
in cell culture models, SASP components can disrupt normal tis-
sue structures and function and promote malignant phenotypes
in neighboring cells. For example, SASP matrix metalloprotei-
nases prevent mammary alveolar morphogenesis and milk pro-
tein production (Parrinello et al., 2005). The SASP cytokines
IL-6, IL-8, and GRO-a stimulate the proliferation of premalignant
or malignant epithelial cells (Coppe´ et al., 2008; Wang et al.,
2006). VEGF, another SASP component, can further promote
angiogenesis to provide progressing tumors with an adequate
nutrient supply (Coppe´ et al., 2006). Interestingly, a recent study
in flies identified loss of Lamin-B, which also occurs in senescent
cells (Freund et al., 2012), in the fly adipose tissue (fat body) as a
potential driver of systemic inflammation (Chen et al., 2014).
Immune modulators secreted from the inflamed fat body influ-
ence innate immune function and regenerative homeostasis
also in distant tissues like the gut epithelium, suggesting an
endocrine mechanism by which accumulated senescent cellspromote loss of proliferative homeostasis systemically (Chen
et al., 2014). Immune senescence and the loss of proliferative ho-
meostasis in the intestinal epithelium of flies are tightly linked and
contribute to age-related mortality (Biteau et al., 2010; Guo et al.,
2014; Rera et al., 2012).
Studies on CC in flies have also inspired new approaches to
understanding and potentially treating proliferative and degener-
ative diseases in mammals. Thus, CC has been suggested to
play a central role in cancer in mammals (Moreno, 2008). The
hypothesis put forward by Moreno suggests that targeting the
process of CC, which potentiates the propagation of cells with
a proliferative advantage, could be an effective anticancer
therapy. This idea has been supported by the observation that
FWE-deficient mice, in which tumorigenic winner cells are ex-
pected to lose their competitive advantage, have reduced sus-
ceptibility to skin papilloma formation (Petrova et al., 2012).
Furthermore, in the thymus, CC was recently shown to act as a
tumor suppressor mechanism. Here, introducing improved
CC efficiency by progenitor repopulation with young-fit bone
marrow-derived progenitors prevented malignant transforma-
tion (Martins et al., 2014). Finally, artificially induced CC has
been proposed as a cell-replacement strategy in the mammalian
heart, where it can efficiently promote cardiomyocyte elimination
and substitution without affecting heart anatomy or function (Villa
del Campo et al., 2014).Developmental Cell 32, January 12, 2015 ª2015 Elsevier Inc. 15
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in vertebrates is the cellular response to DNA-damaging thera-
pies for cancer treatment (Figure 2). These therapies can cause
cellular senescence in the cancerous lesion and surrounding
normal tissue. A recent analysis of middle-aged adults who
were treated with genotoxic therapies for childhood cancer
showed a striking acceleration of multiple age-related pathol-
ogies, including vascular disease and new cancers unrelated
to their childhood tumors (Hudson et al., 2013). Further, ther-
apy-induced senescent cells were shown to reduce the effect
of subsequent therapies through the secretion of a WNT protein,
which promoted cancer cell survival and disease progression
(Sun et al., 2012). Finally, a recent study reported a role for the
SASP in promoting obesity-induced cancer (Yoshimoto et al.,
2013). Dietary or genetic obesity induced cellular senescence
of hepatic stellate cells through DNA damage caused by a
bacterial metabolite produced by the obesity-modified gut
microbiome. The SASP of these senescent cells contained
proinflammatory and protumorigenic factors that, in turn,
promoted the development and progression of hepatocellular
carcinoma.
Conclusions
CC and CP, mediated by paracrine signals, are clearly ancient
mechanisms employed by developing metazoans to ensure
proper morphogenesis and organogenesis and by adult organ-
isms to promote tissue homeostasis. In young adult organisms,
paracrine signaling thus ensures balanced tissue maintenance
and repair. Later in life, however, these signaling mechanisms
can be maladaptive and drive both degenerative and hyper-
plastic changes associated with aging. A striking feature of
both the positive and negative effects of paracrine signaling is
its evolutionary conservation. Thus, organisms as different as
fruit flies and mice (and humans) share many features of positive
and negative paracrine signaling. The ability to harness the
power of genetics in less complex organisms thus holds great
promise for obtaining unique insights and developing novel ther-
apies geared toward optimizing the beneficial effects of para-
crine signaling in the aging organism.
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